Predictive Oncology Inc. (POAI)

Predictive Oncology Revenue

Predictive Oncology had revenue of $345.69K in the quarter ending September 30, 2024, a decrease of -48.91%. This brings the company's revenue in the last twelve months to $1.48M, down -11.21% year-over-year. In the year 2023, Predictive Oncology had annual revenue of $1.78M with 18.24% growth.

• Revenue (ttm): $1.48M
• Revenue Growth: -11.21%
• P/S Ratio: 4.69
• Revenue / Employee: $42,406
• Employees: 35
• Market Cap: 9.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.78M	274.63K	18.24%
Dec 31, 2022	1.51M	84.78K	5.97%
Dec 31, 2021	1.42M	168.41K	13.45%
Dec 31, 2020	1.25M	-159.29K	-11.28%
Dec 31, 2019	1.41M	-90.00	-0.01%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.